Parker Waichman LLP Headlines by Topic
Heparin
FDA Slams Conditions at Chinese Plant Implicated in Heparin Debacle
Apr 22, 2008
| Parker Waichman LLP
Conditions at the Chinese plant that produced a raw ingredient for tainted heparin have been deemed "unsuitable" by the US Food & Drug...
FDA Inspections of Foreign Drug Makers Still Lacking, GAO Audit Says
Apr 22, 2008
| Parker Waichman LLP
The Food & Drug Administration (FDA) is inspecting more foreign drug makers than it once did, but is still only conducting a fraction of the...
Heparin Problems Not Our Fault, Chinese Official Says
Apr 21, 2008
| Parker Waichman LLP
A counterfeit ingredient found in batches of recalled heparin is not to blame for the deaths and reactions seen in U.S. patients treated with the...
FDA China Office Slated to Open in October
Apr 15, 2008
| Parker Waichman LLP
A month from now, the US Food & Drug Administration (FDA) could have full-time personnel on the ground in China, provided the Chinese government...
FDA Commissioner Says Heparin Contamination Probably "Fraud"
Apr 15, 2008
| Parker Waichman LLP
A heparin ingredient sourced from China was likely intentionally replaced with a counterfeit ingredient, the head of the Food & Drug...
Heparin Problems Underscore FDA Failure to Regulate Foreign-Made Drugs
Apr 11, 2008
| Parker Waichman LLP
Tainted heparin sourced from China has brought attention to the problems that can occur when vital drug manufacturing is moved overseas. ...
Is it Time for "Country of Origin" Labels on Drugs?
Apr 9, 2008
| Parker Waichman LLP
Many wonder why items such as fruit clearly indicate country of origin, but medications do not. In the wake of the recent heparin catastrophe,...
Heparin Scandal Leads to More Questions on Overseas Drug Makers
Apr 2, 2008
| Parker Waichman LLP
Heparin is a blood thinner is administered in surgery and other critical care areas to prevent blood clots, is crucial in dialysis and heart surgery,...
Heparin Problems Spark Concerns Over Animal-Derived Drugs
Apr 1, 2008
| Parker Waichman LLP
Scientists have had concerns about animal-derived drugs for some time now; however, they also know creating synthetic alternatives has not always...
Heparin Syringes Recalled by Covidien Ltd.
Mar 31, 2008
| Parker Waichman LLP
Covidien Ltd., is the latest company to recall a heparin product over concerns that the drug may contain a contaminant that could be responsible for...
ParkerWaichmanLLP
@ParkerWaichman
parkerwaichman
parkerwaichmanllp